Moreover, this study further demonstrated that SRPX2 siRNA-loaded liposomes, administrated by the intratracheal way, displayed good antifibrosis effects on BLM-induced pulmonary fibrosis in mice and significantly reduced FMT [11]. The gene discussed is SRPX2; the disease is pulmonary fibrosis.